This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated with improved survival in both newly diagnosed & recurrent glioblastoma compared with matched controls who received SOC treatment. https://t.co/Uso7Pkh1Kt
In a meeting with @MHRAgovuk today, @DrCaliff_FDA & FDA senior officials were briefed about the UK’s new pathways for supporting the development of innovative medical products.
The group also shared ways to jointly support diversity and inclusion in clinical trials, and how to… pic.twitter.com/Gg0mTwc767